39th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190290673 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HBV INFECTION | 2019-09-26 |
20190290674 | Composition for Promoting Production of Immunostimulatory Factor | 2019-09-26 |
20190290675 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | 2019-09-26 |
20190290676 | ANTIBACTERIAL WOUND DRESSING, METHOD FOR PREPARING THE SAME, AND USE THEREOF | 2019-09-26 |
20190290677 | HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS | 2019-09-26 |
20190290678 | COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK | 2019-09-26 |
20190290679 | ADMINISTRATION OF SYNERGISTIC AMOUNTS OF MODIFIED CITRUS PECTIN AND HONOKIOL TO TREAT INFLAMMATION AND ANTI-OXIDANT NEEDS | 2019-09-26 |
20190290680 | GLYCOLIPID COMPOSITIONS AND METHODS OF USE | 2019-09-26 |
20190290681 | COMPOSITIONS, SYSTEMS, KITS, AND METHODS FOR TREATING AN INFECTION | 2019-09-26 |
20190290682 | COMPOSITION FOR PRODUCING HYDROGEN RICH WATER AND OTHER PRODUCTS | 2019-09-26 |
20190290683 | MEDICINAL COMPOSITION FOR IMPROVING AND/OR STABILIZING CIRCULATORY DYNAMICS AFTER ONSET OF HEMORRHAGIC SHOCK | 2019-09-26 |
20190290684 | SOLID PHARMACEUTICAL TABLET | 2019-09-26 |
20190290685 | COMPOSITIONS AND ASSOCIATED METHODS OF MESOPOROUS NANOPARTICLES COMPRISING PLATINUM-ACRIDINE MOLECULES | 2019-09-26 |
20190290686 | ARTIFICIAL ANTIGEN PRESENTING CELLS AND METHODS OF USE | 2019-09-26 |
20190290687 | METHODS OF TREATING OR PREVENTING ALZHEIMER'S DISEASE AND ASSOCIATED CONDITIONS | 2019-09-26 |
20190290688 | METHODS AND REAGENTS FOR MODULATING MACROPHAGE PHENOTYPE | 2019-09-26 |
20190290689 | ANTI-AGEING PHARMACEUTICAL PREPARATION | 2019-09-26 |
20190290690 | COMPOSITIONS COMPRISING ADJUSTABLE CONCENTRATIONS OF GROWTH FACTORS DERIVED FROM BLOOD SERUM AND CLOT HYPOXIA-CONDITIONED MEDIUM AND METHODS OF THEIR PRODUCTION | 2019-09-26 |
20190290691 | FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE | 2019-09-26 |
20190290692 | HUMANIZED ANTI-MUC1* ANTIBODIES AND USE OF CLEAVAGE ENZYME | 2019-09-26 |
20190290693 | PDL1 BLOCK CAR-T TRANSGENIC VECTOR FOR SUPPRESSING IMMUNE ESCAPE, PREPARATION METHOD THEREOF, AND APPLICATION OF THE SAME | 2019-09-26 |
20190290694 | STABLY ENGINEREED PROTEASOME INHIBITOR RESISTANT IMMUNE CELLS FOR IMMUNOTHERAPY | 2019-09-26 |
20190290695 | MICRO-SLITS FOR RETICULOCYTE MATURATION | 2019-09-26 |
20190290696 | HUMAN PLATELET LYSATE DERIVED EXTRACELLULAR VESICLES FOR USE IN MEDICINE | 2019-09-26 |
20190290697 | IPSC-BASED VACCINE AS A PROPHYLACTIC AND THERAPEUTIC TREATMENT FOR CANCER | 2019-09-26 |
20190290698 | Methods of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity | 2019-09-26 |
20190290699 | ISOLATION, CULTIVATION AND USES OF STEM/PROGENITOR CELLS | 2019-09-26 |
20190290700 | DERIVATION AND SELF-RENEWAL OF ISI1+ CELLS AND USES THEREOF | 2019-09-26 |
20190290701 | PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS | 2019-09-26 |
20190290702 | AMELIORATION AND TREATMENT OF PERINATAL BRAIN DAMAGE WITH PLURIPOTENT STEM CELLS | 2019-09-26 |
20190290703 | Compositions and Methods for the Treatment of Hepatic Diseases and Disorders | 2019-09-26 |
20190290704 | PROBIOTIC RECOLONISATION THERAPY | 2019-09-26 |
20190290705 | PROBIOTICS FOR ALTERING THE COMPOSITION OF ORAL BIOFILMS | 2019-09-26 |
20190290706 | NEW MEDICAL USE OF PROBIOTICS | 2019-09-26 |
20190290707 | PROBIOTIC COMPOSITION FOR PREVENTING, IMPROVING OR ALLEVIATING PANCREATIC CANCER AND APPLICATION THEREOF | 2019-09-26 |
20190290708 | PROBIOTIC PATHOGEN INHIBITION COMPOSITION AND METHOD | 2019-09-26 |
20190290709 | BACTERIOPHAGE COMPOSITIONS COMPRISING RESPIRATORY ANTIBACTERIAL PHAGES AND METHODS OF USE THEREOF | 2019-09-26 |
20190290710 | USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD | 2019-09-26 |
20190290711 | TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7) | 2019-09-26 |
20190290712 | DUNALIELLA MUTANT AND METHOD FOR PRODUCING PIGMENT BY USING SAME | 2019-09-26 |
20190290713 | Medical Compositions and Kits Including Those Compositions II | 2019-09-26 |
20190290714 | THERAPEUTIC COMPOSITIONS AND USES THEREOF FOR ALLEVIATING PAIN | 2019-09-26 |
20190290715 | A AI BERRY SEED EXTRACT, FRACTIONS OF A AI BERRY SEED EXTRACTS, PROCESS FOR OBTAINING A AI BERRY SEED EXTRACTS, PHARMACEUTICAL AND FOOD COMPOSITIONS AND METHOD FOR THE TREATMENT OF DISEASES OR DISORDERS WITH A AI BERRY SEED EXTRACT | 2019-09-26 |
20190290716 | BLACK RICE SPROUTING LIQUID HAVING ANTI-INFLAMMATORY EFFECT AND MANUFACTURING METHOD THEREOF | 2019-09-26 |
20190290717 | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE AND/OR INJURY | 2019-09-26 |
20190290718 | COMPOSITION COMPRISING BORTEZOMIB | 2019-09-26 |
20190290719 | MEDICAL DEVICES | 2019-09-26 |
20190290720 | COMPOSITION FOR CELL PROTECTION CONTAINING CYCLO HISTIDINE-PROLINE AS ACTIVE INGREDIENT | 2019-09-26 |
20190290721 | COMBINATION | 2019-09-26 |
20190290722 | TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY | 2019-09-26 |
20190290723 | HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME | 2019-09-26 |
20190290724 | COMPOSITIONS AND USES THEREOF | 2019-09-26 |
20190290725 | USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS | 2019-09-26 |
20190290726 | PROTEIN POLYMER FUSIONS FOR SUBCUTANEOUS DELIVERY OF SMALL MOLECULES | 2019-09-26 |
20190290727 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER | 2019-09-26 |
20190290728 | METHODS RELATED TO BREAKING T CELL EXHAUSTION | 2019-09-26 |
20190290729 | PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF | 2019-09-26 |
20190290730 | METHODS AND COMPOSITIONS FOR STIMULATION OF CELL PROLIFERATION AND PROVISION OF BIOLOGICALLY ACTIVE MIXTURES OF FGF2 ISOFORMS | 2019-09-26 |
20190290731 | INJECTABLE BONE MORPHOGENETIC PROTEIN | 2019-09-26 |
20190290732 | COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION | 2019-09-26 |
20190290733 | CONJUGATES OF AN IL-7 MOIETY AND A POLYMER | 2019-09-26 |
20190290734 | COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF | 2019-09-26 |
20190290735 | ORALLY ADMINISTRABLE PHARMACEUTICAL PREPARATION CONTAINING PROTEIN | 2019-09-26 |
20190290736 | TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS | 2019-09-26 |
20190290737 | NOVEL FORMULATIONS | 2019-09-26 |
20190290738 | METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES | 2019-09-26 |
20190290739 | REDUCED OXYGEN CARRIERS AND THEIR USE FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA | 2019-09-26 |
20190290740 | Albumin-Free Botulinum Toxin Formulations | 2019-09-26 |
20190290741 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION | 2019-09-26 |
20190290742 | TERMINALLY MODIFIED RNA | 2019-09-26 |
20190290743 | Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance | 2019-09-26 |
20190290744 | CHIMERIC ANTIGEN RECEPTORS THAT BIND TO SSEA4 AND USES THEREOF | 2019-09-26 |
20190290745 | Compositions and Methods for Generating an Immune Response to a Tumor Associated Antigen | 2019-09-26 |
20190290746 | PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS | 2019-09-26 |
20190290747 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF | 2019-09-26 |
20190290748 | ANTIGENS AND ANTIGEN COMBINATIONS | 2019-09-26 |
20190290749 | IMMUNE MODULATOR AND VACCINE COMPOSITION CONTAINING THE SAME | 2019-09-26 |
20190290750 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS | 2019-09-26 |
20190290751 | MARBURGVIRUS CONSENSUS ANTIGENS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME | 2019-09-26 |
20190290752 | OPTIMIZED POLYPEPTIDE FOR A SUBUNIT VACCINE AGAINST AVIAN REOVIRUS | 2019-09-26 |
20190290753 | COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS | 2019-09-26 |
20190290754 | VACCINE COMPOSITION COMPRISING HEPATITIS B VIRUS-LIKE PARTICLE AS ADJUVANT | 2019-09-26 |
20190290755 | B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES | 2019-09-26 |
20190290756 | PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D | 2019-09-26 |
20190290757 | TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY | 2019-09-26 |
20190290758 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | 2019-09-26 |
20190290759 | COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT OF OVARIAN CANCER | 2019-09-26 |
20190290760 | FUNGAL VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2019-09-26 |
20190290761 | MAGNETIC PARTICLE CONJUGATES, MICELLES, AND METHODS OF DELIVERING AGENTS | 2019-09-26 |
20190290762 | NANO-ARCHITECTURED COLLOIDOSOMES FOR CONTROLLED AND TRIGGERED RELEASE | 2019-09-26 |
20190290763 | METHODS FOR PHOTODYNAMIC THERAPY | 2019-09-26 |
20190290764 | SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER | 2019-09-26 |
20190290765 | Method of Reducing Formation of Etanercept Aggregates or Fragments | 2019-09-26 |
20190290766 | Stable Aqueous Etanercept Composition | 2019-09-26 |
20190290767 | Method of Reducing Formation of Etanercept Aggregates or Fragments | 2019-09-26 |
20190290768 | Stable Aqueous Etanercept Composition | 2019-09-26 |
20190290769 | Hydrogel Compositions | 2019-09-26 |
20190290770 | METHOD FOR PRESERVING AND STABILIZING PROTEINS FOR FORMULATIONS OF SANITARY, PHARMACEUTICAL AND COSMETIC PRODUCTS | 2019-09-26 |
20190290771 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | 2019-09-26 |
20190290772 | GLUCAGON-LIKE PEPTIDE-1-T3 CONJUGATES | 2019-09-26 |